Insider · CIK 0001215188
Debra A Cafaro
Files at PNC (PNC FINANCIAL SERVICES GROUP, INC.), VTR (Ventas, Inc.). First filing Oct 28, 2024, latest Mar 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VTR: Ventas, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Ventas, Inc. | $3.0M 42,882 shares | -4% | - | |
| 20Weak | Ventas, Inc. | $15M 224,359 shares | -20% | - | |
| 20Weak | Ventas, Inc. | $10M 155,333 shares | -14% | - | |
| 15Weak | Ventas, Inc. | $5.3M 80,767 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | PNC PNC FINANCIAL SERVICES GROUP, INC. | AGrant or award Phantom Stock Unitderivativeindirect: Deferred Compensation Plan | +119 | $220.75 | $26k | 9,835 | 6 d ago |
| Mar 19, 2025 | VTR Ventas, Inc. | AGrant or award Common Stock | +17,552 | $67.58 | $1.2M | 1,145,695 | Mar 19, 2025 |
| Feb 28, 2025 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +41,294 | $63.24 | $2.6M | 1,179,437 | Mar 4, 2025 |
| Feb 28, 2025 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -41,294 | $69.08 | $2.9M | 1,138,143 | Mar 4, 2025 |
| Mar 3, 2025 | VTR Ventas, Inc. | GGift Common Stock10b5-1 | -10,000 | $0.00 | $0 | 1,128,143 | Mar 4, 2025 |
| Mar 3, 2025 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +388 | $62.22 | $24k | 1,128,531 | Mar 4, 2025 |
| Mar 3, 2025 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -388 | $71.00 | $28k | 1,128,143 | Mar 4, 2025 |
| Mar 4, 2025 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +1,200 | $62.22 | $75k | 1,129,343 | Mar 4, 2025 |
| Mar 4, 2025 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -1,200 | $71.04 | $85k | 1,128,143 | Mar 4, 2025 |
| Feb 28, 2025 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -41,294 | $0.00 | $0 | 779,036 | Mar 4, 2025 |
| Mar 3, 2025 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -388 | $0.00 | $0 | 778,648 | Mar 4, 2025 |
| Mar 4, 2025 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,200 | $0.00 | $0 | 777,448 | Mar 4, 2025 |
| Feb 24, 2025 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +9,680 | $62.22 | $602k | 1,147,823 | Feb 26, 2025 |
| Feb 24, 2025 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -9,680 | $68.00 | $658k | 1,138,143 | Feb 26, 2025 |
| Feb 25, 2025 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +214,679 | $62.22 | $13M | 1,352,822 | Feb 26, 2025 |
| Feb 25, 2025 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -214,679 | $68.22 | $15M | 1,138,143 | Feb 26, 2025 |
| Feb 24, 2025 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,680 | $0.00 | $0 | 1,035,009 | Feb 26, 2025 |
| Feb 25, 2025 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -214,679 | $0.00 | $0 | 820,330 | Feb 26, 2025 |
| Feb 18, 2025 | VTR Ventas, Inc. | AGrant or award Common Stock | +206,110 | $0.00 | $0 | 1,229,447 | Feb 19, 2025 |
| Feb 18, 2025 | VTR Ventas, Inc. | FTax withholding Common Stock | -91,304 | $66.77 | $6.1M | 1,138,143 | Feb 19, 2025 |
| Feb 1, 2025 | VTR Ventas, Inc. | FTax withholding Common Stock | -4,961 | $60.42 | $300k | 1,038,691 | Feb 3, 2025 |
| Feb 1, 2025 | VTR Ventas, Inc. | FTax withholding Common Stock | -7,668 | $60.42 | $463k | 1,031,023 | Feb 3, 2025 |
| Feb 1, 2025 | VTR Ventas, Inc. | FTax withholding Common Stock | -7,686 | $60.42 | $464k | 1,023,337 | Feb 3, 2025 |
| Jan 2, 2025 | PNC PNC FINANCIAL SERVICES GROUP, INC. | AGrant or award Phantom Stock Unitderivativeindirect: Deferred Compensation Plan | +137 | $191.39 | $26k | 7,966 | Jan 6, 2025 |
| Jan 2, 2025 | VTR Ventas, Inc. | AGrant or award Common Stock | +56,935 | $57.96 | $3.3M | 1,043,652 | Jan 2, 2025 |
| Oct 29, 2024 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +121,248 | $65.94 | $8.0M | 1,107,965 | Oct 31, 2024 |
| Oct 29, 2024 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -121,248 | $66.17 | $8.0M | 986,717 | Oct 31, 2024 |
| Oct 30, 2024 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +34,085 | $65.94 | $2.2M | 1,020,802 | Oct 31, 2024 |
| Oct 30, 2024 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -34,085 | $66.67 | $2.3M | 986,717 | Oct 31, 2024 |
| Oct 29, 2024 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -121,248 | $0.00 | $0 | 1,220,432 | Oct 31, 2024 |
| Oct 30, 2024 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -34,085 | $0.00 | $0 | 1,186,347 | Oct 31, 2024 |
| Oct 24, 2024 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +74,763 | $65.94 | $4.9M | 1,061,480 | Oct 28, 2024 |
| Oct 24, 2024 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -74,763 | $66.10 | $4.9M | 986,717 | Oct 28, 2024 |
| Oct 25, 2024 | VTR Ventas, Inc. | MOption exercise Common Stock10b5-1 | +6,004 | $65.94 | $396k | 992,721 | Oct 28, 2024 |
| Oct 25, 2024 | VTR Ventas, Inc. | SOpen-market sale Common Stock10b5-1 | -6,004 | $66.11 | $397k | 986,717 | Oct 28, 2024 |
| Oct 24, 2024 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -74,763 | $0.00 | $0 | 1,347,684 | Oct 28, 2024 |
| Oct 25, 2024 | VTR Ventas, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,004 | $0.00 | $0 | 1,341,680 | Oct 28, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.